UB Paderborn / Katalog / Suche / in CDI

Immunothrombosis and its underlying biological mechanisms

Hematology, Transfusion and Cell Therapy, 2024-01, Vol.46 (1), p.49-57

2024

Link zum Volltext

Verfügbarkeit prüfen

Thrombosis Occurrence in COVID-19 Compared With Other Infectious Causes of ARDS: A Contemporary Cohort

Clinical and applied thrombosis/hemostasis, 2023-01, Vol.29, p.10760296231175656-10760296231175656

2023

Link zum Volltext

Verfügbarkeit prüfen

Extracellular vesicles are a late marker of inflammation, hypercoagulability and COVID-19 severity

Hematology, Transfusion and Cell Therapy, 2024-04, Vol.46 (2), p.176-185

2024

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism in critically ill patients with pneumonia in the pre‐COVID‐19 era: Data from a large public database

Research and practice in thrombosis and haemostasis, 2022-10, Vol.6 (7), p.e12816-e12816, Article e12816

2022

Link zum Volltext

Verfügbarkeit prüfen

Should bleeding be a concern in antiphospholipid syndrome?

Research and practice in thrombosis and haemostasis, 2024-01, Vol.8 (1), p.102328-102328, Article 102328

Orsi, Fernanda A.

2024

Link zum Volltext

Verfügbarkeit prüfen

Statin Therapy to Revert Hypercoagulability and Prevent Venous Thromboembolism: A Narrative Review

Seminars in thrombosis and hemostasis, 2019-11, Vol.45 (8), p.825

2019

Link zum Volltext

Verfügbarkeit prüfen

Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib

Journal of thrombosis and thrombolysis, 2023-05, Vol.55 (4), p.770-774

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia

Annals of hematology, 2022-12, Vol.101 (12), p.2781-2784

2022

Link zum Volltext

Verfügbarkeit prüfen

Glucocorticoid use and risk of first and recurrent venous thromboembolism: self‐controlled case‐series and cohort study

British journal of haematology, 2021-06, Vol.193 (6), p.1194-1202

2021

Link zum Volltext

Verfügbarkeit prüfen

Low ectonucleotidase activity and increased neutrophil-platelet aggregates in patients with antiphospholipid syndrome

Blood, 2024-03, Vol.143 (12), p.1193

2024

Link zum Volltext

Verfügbarkeit prüfen

A retrospective analysis of 122 immune thrombocytopenia patients treated with dapsone: Efficacy, safety and factors associated with treatment response

Journal of thrombosis and haemostasis, 2021-09, Vol.19 (9), p.2275-2286

2021

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms and Mutations in vWF and ADAMTS13 Genes and Their Correlation With Plasma Levels of FVIII and vWF in Patients With Deep Venous Thrombosis

Clinical and applied thrombosis/hemostasis, 2011-10, Vol.17 (5), p.514-518

2011

Link zum Volltext

Verfügbarkeit prüfen

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

Journal of thrombosis and haemostasis, 2019-02, Vol.17 (2), p.319-328

2019

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory markers in thrombosis associated with primary antiphospholipid syndrome

Journal of thrombosis and thrombolysis, 2020-11, Vol.50 (4), p.772-781

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of a hypolipid diet in patients with primary antiphospholipid syndrome with dyslipidemia: a prospective study

Journal of thrombosis and thrombolysis, 2022-02, Vol.53 (2), p.390-398

2022

Link zum Volltext

Verfügbarkeit prüfen

Residual Vein Thrombosis Echogenicity Is Associated to the Risk of DVT Recurrence: A Cohort Study

Clinical and applied thrombosis/hemostasis, 2018-04, Vol.24 (3), p.477-482

2018

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil activation and circulating neutrophil extracellular traps are increased in venous thromboembolism patients for at least one year after the clinical event

Journal of thrombosis and thrombolysis, 2022-01, Vol.53 (1), p.30-42

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-term prospective study of recurrent venous thromboembolism in a Hispanic population

Blood coagulation & fibrinolysis, 2010-10, Vol.21 (7), p.660-665

2010

Link zum Volltext

Verfügbarkeit prüfen

Association between plasmatic oxidative stress and thrombosis in primary antiphospholipid syndrome

Journal of thrombosis and thrombolysis, 2021-10, Vol.52 (3), p.730-737

2021

Link zum Volltext

Verfügbarkeit prüfen

Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk

Clinical epidemiology, 2019-07, Vol.11, p.625-633

2019

Link zum Volltext

Verfügbarkeit prüfen

Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels

Thrombosis research, 2014-05, Vol.133 (5), p.736-742

2014

Link zum Volltext

Verfügbarkeit prüfen

Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case-control study comparing dengue fever patients with and without bleeding manifestations

BMC infectious diseases, 2013-07, Vol.13 (1), p.350-350, Article 350

2013

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis of Scott syndrome in patient with bleeding disorder of unknown cause

Blood coagulation & fibrinolysis, 2012-01, Vol.23 (1), p.75-77

2012

Link zum Volltext

Verfügbarkeit prüfen

Genetic variations in sites of affinity between FVIII and LRP1 are not associated with high FVIII levels in venous thromboembolism

Scientific reports, 2015-03, Vol.5 (1), p.9246-9246, Article 9246

2015

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Immunothrombosis and its underlying biological mechanisms

Thrombosis Occurrence in COVID-19 Compared With Other Infectious Causes of ARDS: A Contemporary Cohort

Extracellular vesicles are a late marker of inflammation, hypercoagulability and COVID-19 severity

Venous thromboembolism in critically ill patients with pneumonia in the pre‐COVID‐19 era: Data from a large public database

Should bleeding be a concern in antiphospholipid syndrome?

Statin Therapy to Revert Hypercoagulability and Prevent Venous Thromboembolism: A Narrative Review

Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib

Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia

Glucocorticoid use and risk of first and recurrent venous thromboembolism: self‐controlled case‐series and cohort study

Low ectonucleotidase activity and increased neutrophil-platelet aggregates in patients with antiphospholipid syndrome

Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses

A retrospective analysis of 122 immune thrombocytopenia patients treated with dapsone: Efficacy, safety and factors associated with treatment response

Polymorphisms and Mutations in vWF and ADAMTS13 Genes and Their Correlation With Plasma Levels of FVIII and vWF in Patients With Deep Venous Thrombosis

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

Inflammatory markers in thrombosis associated with primary antiphospholipid syndrome

Efficacy of a hypolipid diet in patients with primary antiphospholipid syndrome with dyslipidemia: a prospective study

Residual Vein Thrombosis Echogenicity Is Associated to the Risk of DVT Recurrence: A Cohort Study

Neutrophil activation and circulating neutrophil extracellular traps are increased in venous thromboembolism patients for at least one year after the clinical event

Long-term prospective study of recurrent venous thromboembolism in a Hispanic population

Association between plasmatic oxidative stress and thrombosis in primary antiphospholipid syndrome

Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk

Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels

Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case-control study comparing dengue fever patients with and without bleeding manifestations

Diagnosis of Scott syndrome in patient with bleeding disorder of unknown cause

Genetic variations in sites of affinity between FVIII and LRP1 are not associated with high FVIII levels in venous thromboembolism

Suchergebnisse filtern